Mayall
Frederick Mayall, Exeter GB
Patent application number | Description | Published |
---|---|---|
20150050683 | Device And Method - A device comprising a housing and a cell block material, wherein the housing has a first end which is adapted to engage with sampling means via a gas tight fit, at least part of the cell block material is positioned within the housing such that, in use, the cell block material is in fluid connection with the sampling means, and the cell block material protrudes from the first end of the housing such that, in use, the cell block material extends into the sampling means. | 02-19-2015 |
James Mayall, Carlsbad, CA US
Patent application number | Description | Published |
---|---|---|
20110101104 | METHOD AND SOFTWARE FOR LABELING AN ELECTRONIC DEVICE - A method is provided for designing and printing a label that can be applies to an electronic device having a planar and/or a non-planar surface and a view screen, such as an iPodĀ® electronic music player or other MP3 player, a personal digital assistant, or a cell phone. The method provides a label and electronic view screen image that both apply to the device and together give an appearance of a seamless cover on the electronic device. | 05-05-2011 |
John Mayall, Manchester GB
Patent application number | Description | Published |
---|---|---|
20120212538 | Printing Process - A process for printing an image on a substrate comprising the steps of: (a) applying an ink comprising polymer-encapsulated pigment particles and an aqueous medium to a substrate by means of an ink jet printer, wherein (i) the said particles are dispersed in the aqueous medium, and (ii) the said particles comprise a carboxy-functional dispersant crosslinked around a pigment core by a first crosslinking agent; and (b) crosslinking the polymer-encapsulated pigment particles with a second crosslinking agent. The process is particularly useful for printing polymeric substrates which come into contact with rubbing and/or moisture. | 08-23-2012 |
Richard Mayall, London GB
Patent application number | Description | Published |
---|---|---|
20110047114 | METHOD, APPARATUS AND COMPUTER PROGRAM FOR ENABLING MANAGEMENT OF RISK AND/OR OPPORTUNITY - The invention relates to a method for enabling management of at least one opportunity having a maximum opportunity level and to which one or more exploits that realise the opportunity can be applied, the method comprising: (i) determining the total opportunity improvement of all exploits applicable to at least one opportunity assuming that all said exploits are fully applied to realise the opportunity and that all said exploits are independent of each other; (ii) determining the contribution of the or each said exploit to said total opportunity increase; (iii) determining the level of actual opportunity increase from each said exploit taking into account, for each of said exploits, the contribution of the or each exploit to said total opportunity increase, the dependency of the exploit on other exploits applicable to said opportunity, and the degree to which the exploit is applied to realise said opportunity; and, (iv) determining from said levels of actual opportunity increase from each said exploit the total actual result improvement applied to said result. | 02-24-2011 |
Robert Matthew Mayall, Calgary CA
Patent application number | Description | Published |
---|---|---|
20150083612 | System and Methods For The Detection of Multiple Chemical Compounds - Methods that may be used for the electrochemical detection of multiple parameters, including chemical compounds. Further provided are cells that may be used in the electrochemical detection of multiple parameters, including chemical compounds, as well as a kit for the electrochemical detection of multiple parameters, including chemical compounds. | 03-26-2015 |
Timothy P. Mayall, Encinitas, CA US
Patent application number | Description | Published |
---|---|---|
20100008889 | ADENOVIRAL EXPRESSION VECTORS - The present invention provides a recombinant adenovirus vector characterized by the partial or total deletion of adenoviral E2B function and having an expression cassette containing a heterologous sequence encoding a protein of interest inserted into the E1 region. Such vectors are designed to reduce or eliminate the occurrence of replication competent adenovirus contamination. Additionally, the expression cassette of the vector may contain one or more regulatory elements capable of increasing the expression of the heterologous sequence and/or reducing the expression of viral proteins. Such a reduction in expression of viral proteins reduces the cytotoxicty and immunogenicity of the adenovirus vectors when administered in vivo. Transformed production host cells and a method of producing recombinant proteins and gene therapy also are included within the scope of this invention. | 01-14-2010 |
20110123564 | ADENOVIRAL-BASED VECTORS - The present invention provides replication competent adenoviral vectors capable of expressing antigens from infectious pathogens, such as influenza virus. The adenoviral vectors can be used to vaccinate subjects against the infectious pathogens. The adenoviral vectors comprise heterologous sequences encoding the antigens. The heterologous sequences can be inserted into various locations in the adenoviral vectors, including in or near specific E3 deletions and/or integrated into the adenoviral hexon coding region. The adenoviral vectors can be derived from any adenoviral serotype, particularly an Ad4 or Ad7 serotype. | 05-26-2011 |
20150086579 | ADENOVIRAL-BASED VECTORS - The present invention provides replication competent adenoviral vectors capable of expressing antigens from infectious pathogens, such as influenza virus. The adenoviral vectors can be used to vaccinate subjects against the infectious pathogens. The adenoviral vectors comprise heterologous sequences encoding the antigens. The heterologous sequences can be inserted into various locations in the adenoviral vectors, including in or near specific E3 deletions and/or integrated into the adenoviral hexon coding region. The adenoviral vectors can be derived from any adenoviral serotype, particularly an Ad4 or Ad7 serotype. | 03-26-2015 |